Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Nicolas Duployez · SciRah

Researcher profile · Semantic Scholar

Nicolas Duployez

Share profile

Nicolas Duployez — researcher profile on SciRah

h-index: 31
Works: 206
Citations: 3,037

Most-cited papers

PFMG2025–integrating genomic medicine into the national healthcare system in France
Caroline Abadie, Aldja Abderrahmane, Ouarda Abdous, Carine Abel +496 more
2025The Lancet Regional Health - Europe61 citations Open access
Semantic Scholar
Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia
Sara K. Silbert, Alexander W. Rankin, Chloe N. Hoang, A. Semchenkova +77 more
2025Blood51 citations Open access
Semantic Scholar
Prognostic impact of CEBPA mutational subgroups in adult AML
J. Georgi, S. Stasik, Michael Kramer, M. Meggendorfer +34 more
2024Leukemia43 citations Open access
Semantic Scholar
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
Claire C. Homan, M. Drazer, Kai Yu, D. Lawrence +61 more
2023Blood Advances36 citations Open access
Semantic Scholar
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia
Nicolas Duployez, Loic Vasseur, R. Kim, Laetitia Largeaud +25 more
2023Leukemia31 citations Open access
Semantic Scholar
Somatic genetic alterations predict hematological progression in GATA2 deficiency
Laetitia Largeaud, M. Collin, Nils Monselet, F. Vergez +22 more
2023Haematologica28 citations Open access
Semantic Scholar
Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?
Nicolas Gazeau, D. Beauvais, R. Tilmont, M. Srour +18 more
2025Leukemia22 citations Open access
Semantic Scholar
Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia
Eleanor L. Woodward, Minjun Yang, L. Moura-Castro, H. van den Bos +10 more
2023Nature Communications20 citations Open access
Semantic Scholar
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression
L. Fléchon, I. Arib, Ankit K. Dutta, Lama Hasan Bou Issa +31 more
2024Blood Advances19 citations Open access
Semantic Scholar
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study
Pierre Hirsch, J. Lambert, M. Bucci, Caroline Deswarte +12 more
2024Blood Cancer Journal18 citations Open access
Semantic Scholar
Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement
Fanny Lassalle, Nicolas Duployez, F. Vincent, A. Rauch +9 more
2023JACC: Basic to Translational Science18 citations Open access
Semantic Scholar
Disease characteristics and outcomes of acute myeloid leukemia in germline RUNX1 deficiency (Familial Platelet Disorder with associated Myeloid Malignancy)
M. P. Ernst, J. Versluis, P. Valk, M. Bierings +27 more
2025HemaSphere14 citations Open access
Semantic Scholar
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.
D. Fandrei, Jean Pegliasco, Florence Pasquier, Nathalie Ibrahim +30 more
2025Clinical Cancer Research14 citations
Semantic Scholar
Intermediate-Dose Cytarabine as Postinduction AML Therapy.
M. Hunault, C. Pautas, S. Bertoli, P. Dumas +34 more
2025NEJM Evidence13 citations
Semantic Scholar
Involvement of the JAK‐STAT pathway in the molecular landscape of tyrosine kinase fusion‐negative hypereosinophilic syndromes: A nationwide CEREO study
Matthieu Groh, L. Fenwarth, M. Labro, A. Boudry +38 more
2024American journal of hematology/oncology12 citations Open access
Semantic Scholar
Genomic imbalances analysis provides new insight into prognostic factors in adult and pediatric T-ALL.
E. Balducci, M. Simonin, Nicolas Duployez, T. Steimlé +18 more
2024Blood10 citations
Semantic Scholar
Flow MRD Monitoring Combining Laip/Dfn and CD34+CD38- LSCs Is a Strong Predictor of Outcome in Adult AML Independently of the ELN-2022 Risk: First Results from the Multicentric Acute Leukemia French Intergroup MRD Flow Network
Adriana Plesa, Stéphanie Mathis, F. Dumézy, A. Lhoumeau +34 more
2024Blood10 citations
Semantic Scholar
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
M. Sébert, L. Freiman, C. Chaffaut, A. Guerci +13 more
2024Leukemia9 citations
Semantic Scholar
Favourable Outcomes in Newly Diagnosed Paediatric AML with Gemtuzumab Ozogamicin and Risk-Stratified Therapy: Results from the International Phase III Myechild 01 Trial
Brenda Gibson, André Baruchel, Andrew Moore, Shanna Maycock +32 more
2024Blood9 citations
Semantic Scholar
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
Romane Joudinaud, A. Boudry, L. Fenwarth, S. Geffroy +21 more
2024Blood Advances8 citations Open access
Semantic Scholar
Disease characteristics and monitoring of IDH1/IDH2-mutated acute myeloid leukemia
Mélinda Dantec, Maxime Dufossé, A. Boudry, É. Fournier +13 more
2025Blood Cancer Journal7 citations Open access
Semantic Scholar
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia
D. Lebon, A. da Rocha, B. Cassinat, M. Heiblig +18 more
2025Leukemia7 citations
Semantic Scholar
Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms
T. Mahévas, A. Osio, L. Larcher, E. Clappier +19 more
2024Blood Advances7 citations Open access
Semantic Scholar
European standard clinical practice - Key issues for the medical care of individuals with familial leukemia.
Alisa Förster, Claudia Davenport, Nicolas Duployez, M. Erlacher +18 more
2023European Journal of Medical Genetics7 citations Open access
Semantic Scholar
Tetraspanin CD81 Supports Cancer Stem Cell Function and Represents a Therapeutic Vulnerability in Acute Myeloid Leukemia
Fanny Gonzales, P. Peyrouze, Thomas Boyer, S. Guihard +10 more
2023Blood7 citations Open access
Semantic Scholar
Monitoring molecular changes in the management of myelodysplastic syndromes
Nicolas Duployez, C. Preudhomme
2024British Journal of Haematology6 citations
Semantic Scholar
LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
Loic Vasseur, L. Fenwarth, Jérôme Lambert, S. de Botton +16 more
2023Blood Advances6 citations Open access
Semantic Scholar
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.
Nicolas Duployez, Romane Joudinaud, A. Boudry, M. Hunault +41 more
2026Blood5 citations Open access
Semantic Scholar
Myeloid neoplasms risks for germline DDX41 pathogenic variants carriers.
M. Villy, Y. Drouet, L. Larcher, Yoan Vial +25 more
2025European Journal of Human Genetics5 citations
Semantic Scholar
Germline CHEK2 mutations in patients with myeloid neoplasms
L. Freiman, L. Larcher, G. Tueur, N. Vasquez +9 more
2024Leukemia5 citations
Semantic Scholar
Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia
Jérôme Tamburini, Sarah Mouche, Clément Larrue, Nicolas Duployez +16 more
2023Blood Advances5 citations Open access
Semantic Scholar
Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups
H. Mathilde, C. Pautas, S. Bertoli, P. Dumas +31 more
2023Blood5 citations Open access
Semantic Scholar
ELN-DAVID recommendations for NGS-based FLT3-ITD MRD testing for patients with acute myeloid leukemia
C. Hourigan, Lisanne Beugelink, Jad Othman, G. Gui +17 more
2026Blood4 citations Open access
Semantic Scholar
Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia
A. Boudry, Laure Goursaud, Delphine Lebon, F. Dumézy +13 more
2025British Journal of Haematology4 citations
Semantic Scholar
Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes
G. Escure, É. Fournier, Cynthia Saade, L. H. B. Issa +18 more
2023Haematologica4 citations Open access
Semantic Scholar
Project Evolve, Evaluation of Lineage Switch (LS), an International Initiative: Preliminary Results Reveal Dismal Outcomes in Patients with LS
Sara K. Silbert, Cynthia Harrison, D. Biery, A. Semchenkova +49 more
2023Blood4 citations Open access
Semantic Scholar
A new combination of monocytic scores to support diagnosis of chronic myelomonocytic leukemia according to novel classifications
B. Podvin, V. Soenen, F. Dumézy, J. Herlem +6 more
2023International Journal of Laboratory Hematology4 citations
Semantic Scholar
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening study
Leïla ben Dhia, Mathieu Wemeau, L. Fenwarth, A. Marceau-Renaut +28 more
2025Blood Cancer Journal3 citations Open access
Semantic Scholar
Influence of Nucleophosmin (NPM1) Genotypes on Outcome of Patients with Acute Myeloid Leukemia: an AIEOP-BFM and COG-SWOG Intergroup Collaboration
C. Tregnago, M. Benetton, R. Ries, Jack H. Peplinski +13 more
2024Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Outcomes for Children with High Risk Acute Myeloid Leukemia on the Myechild 01 International Phase III Clinical Trial
Andrew Moore, Shanna Maycock, G. Leverger, O. Smith +27 more
2023Blood3 citations Open access
Semantic Scholar
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.
Loic Vasseur, M. Duchmann, Nicolas Duployez, Emmanuel Raffoux +27 more
2026Leukemia2 citations
Semantic Scholar
The genomic landscape of acute myeloid leukemia: Redefining classifications, ontogeny, and therapeutic strategies.
Nicolas Duployez, C. Preudhomme
2025Seminars in hematology (Print)2 citations
Semantic Scholar
Clinical impact of FLT3 microclones on outcomes in patients with newly diagnosed FLT3-ITD negative AML: A subanalysis from the pethema quiwi trial
C. Sargas, A. Boudry, Pilar Lloret Madrid, Nicolas Duployez +31 more
2025Blood2 citations
Semantic Scholar
Induction chemotherapy with a single anthracycline-containing cycle in younger adults with newly diagnosed AML – the french backbone intergroup (BIG)-1 study on behalf of the filo, ALFA, and SFGM-TC study groups
Christian Récher, C. Pautas, S. Bertoli, P. Dumas +38 more
2025Blood2 citations
Semantic Scholar
Constitutional and acquired genetic variants in ARID5B in pediatric B‐cell precursor acute lymphoblastic leukemia
Charlotte Ragnarsson, Minjun Yang, L. Moura-Castro, Efe Aydın +10 more
2024Genes, Chromosomes and Cancer2 citations Open access
Semantic Scholar
Venetoclax in Combination with Intermediate Doses of Cytarabine in Consolidation Phase for Acute Myeloid Leukemia Patients in First Complete Remission; Results of the Part 1 of the Phase 1/2 Multicentric Covenidac Study
L. Gastaud, P. Peterlin, M. Hunault, E. Raffoux +18 more
2023Blood2 citations
Semantic Scholar
CEBP and ZEB2 alterations define three distinct subtypes of B‐cell acute lymphoblastic leukemia
R. Kim, M. Passet, Hugo Bergugnat, Loic Vasseur +26 more
2026HemaSphere1 citations Open access
Semantic Scholar
Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia
Fanny Gonzales, P. Peyrouze, Djohana Laurent, Thomas Boyer +16 more
2026Signal Transduction and Targeted Therapy1 citations Open access
Semantic Scholar
Treatments and outcomes of adult patients with TP53-mutated acute myeloid leukemia (AML) in the real-life –Report of the prospective french observational ALFA-PPP study.
J. Micol, R. Itzykson, L. Farnault, T. Cluzeau +19 more
2025Blood1 citations
Semantic Scholar
Transplantation in patients with lower-risk MDS: a prospective phase 2 trial based on donor availability
M. Sébert, S. Thepot, T. Cluzeau, Nicolas Duployez +23 more
2025Blood Advances1 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Preudhomme×29
Invite
C. Preudhomme — researcher profile on SciRah
L. Fenwarth×13
Invite
L. Fenwarth — researcher profile on SciRah
C. Berthon×12
Invite
C. Berthon — researcher profile on SciRah
D. Lebon×11
Invite
D. Lebon — researcher profile on SciRah

×10

Invite

M. Heiblig — researcher profile on SciRah

Karine Celli-Lebras×10

Invite

Karine Celli-Lebras — researcher profile on SciRah

Invite

P. Peterlin — researcher profile on SciRah

Invite

E. Raffoux — researcher profile on SciRah

É. Delabesse×8

Invite

É. Delabesse — researcher profile on SciRah

Hervé Dombret×8

Invite

Hervé Dombret — researcher profile on SciRah

Invite

E. Clappier — researcher profile on SciRah

Invite

T. Cluzeau — researcher profile on SciRah